I agree that this site is using cookies. You can find further informations here.
X
Keeping, Sam
51  results:
Search for persons X
?
1

Clinical impact of rapid molecular diagnostic tests in pati..:

Mojebi, Ali ; Wu, Ping ; Keeping, Sam...
PLOS ONE.  19 (2024)  6 - p. e0303560 , 2024
Link: https://doi.org/10.1371/..
 
?
2

Outcomes of patients aged ≥26 years with relapsed or refrac..:

Minnema, Monique C. ; Yin, Xiang ; Davi, Ruthanna...
Leukemia & Lymphoma.  , 2024
Link: https://doi.org/10.1080/..
 
?
3

Matching-Adjusted Indirect Comparison of Brexucabtagene Aut..:

Salles, Gilles ; Chen, Jenny M. H. ; Zhang, Ina...
Advances in Therapy.  41 (2024)  5 - p. 1938-1952 , 2024
Link: https://doi.org/10.1007/..
 
?
4

An Updated Comparison of Overall Survival with Brexucabtage..:

Hess, Georg ; Dreyling, Martin ; Oberic, Lucie...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S359-S360 , 2024
Link: https://doi.org/10.1016/..
 
?
5

P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS R..:

Thieblemont, Catherine ; Wang, Kaijun ; Keeping, Sam...
HemaSphere.  7 (2023)  S3 - p. e10013c4 , 2023
Link: https://doi.org/10.1097/..
 
?
6

Matching-Adjusted Indirect Comparisons of Brexucabtagene Au..:

Shah, Bijal ; Chen, Jenny M. H. ; Wu, James J....
Advances in Therapy.  40 (2023)  12 - p. 5383-5398 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Indirect treatment comparison of brexucabtagene autoleucel ..:

Hess, Georg ; Dreyling, Martin ; Oberic, Lucie...
Leukemia & Lymphoma.  65 (2023)  1 - p. 14-25 , 2023
Link: https://doi.org/10.1080/..
 
?
8

Impact of the treatment crossover design on comparative eff..:

Feliciano, Josephine Louella ; McLoone, Dylan ; Xu, Yingxin...
Frontiers in Oncology.  12 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
9

P1093: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF ZANU..:

Thieblemont, Catherine ; Wang, Kaijun ; Keeping, Sam...
HemaSphere.  7 (2023)  S3 - p. e8409315 , 2023
Link: https://doi.org/10.1097/..
 
?
10

Correlation Between Early Time-to-Event Outcomes and Overal..:

Black, Christopher M. ; Keeping, Sam ; Mojebi, Ali...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
11

Real‐world experience among patients with relapsed/refracto..:

Hess, Georg ; Dreyling, Martin ; Oberic, Lucie...
British Journal of Haematology.  202 (2022)  4 - p. 749-759 , 2022
Link: https://doi.org/10.1111/..
 
?
12

Cost-Effectiveness of Cemiplimab Versus Standard of Care in..:

Kuznik, Andreas ; Smare, Caitlin ; Chen, Chieh-I...
Value in Health.  25 (2022)  2 - p. 203-214 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Network meta-analysis of immune-oncology monotherapy as fir..:

Freemantle, Nick ; Xu, Yingxin ; Wilson, Florence R....
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592211050 , 2022
Link: https://doi.org/10.1177/..
 
?
14

Poster: CML-353: Health Care Resource Utilization (HCRU) wi..:

Smith, B Douglas ; Cortes, Jorge E ; Rea, Delphine...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S224 , 2021
Link: https://doi.org/10.1016/..
 
?
15

ABCL-289: Matching-Adjusted Indirect Comparison (MAIC) of A..:

Oluwole, Olalekan O ; Chen, Jenny MH ; Chan, Keith...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S388 , 2021
Link: https://doi.org/10.1016/..
 
1-15